111 Capital’s Celestica CLS Stock Holding History

111 Capital’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$679K	Buy	+1,864	New	+$699K	0.12%	177
2025 Q2	–	Sell	-5,839	Closed	-$461K	–	545
2025 Q1	$461K	Buy	+5,839	New	+$619K	0.09%	236

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

111 Capital's CLS Position: Q2 2026 in Review

111 Capital opened a new position in Celestica (CLS) in Q2 2026: 1,864 shares worth $679K. The stake represents 0.12% of the portfolio and ranks #177 among its holdings. This is a return to the name: 111 Capital previously reported a position in CLS as recently as Q1 2025.

111 Capital first reported a position in CLS in Q1 2025 and has held it in 2 quarters since. 878 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

111 Capital held 1,864 shares of Celestica worth $679K as of Q2 2026.
Celestica was a new 111 Capital position in Q2 2026.
Celestica made up 0.12% of 111 Capital's portfolio in Q2 2026, its #177 holding.
111 Capital first reported a position in Celestica in Q1 2025 and has held it in 2 quarters since.
878 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.